Today: 11 March 2026
Subscribe

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Rolls-Royce Soars to Record High: What’s Fueling the Unstoppable Rally?

Rolls-Royce Rockets 40%+ in 2 Years: Jet Engine Boom and £11B Submarine Deal Fuel Rally

Rolls-Royce shares hit 1,176p mid-day Oct 3, 2025, near an all-time high and up 124% in 12 months. Q3 orders reached £8.5bn, up 22% year-on-year, driven by civil and defense contracts. FY2024 revenue rose 15% to £18.9bn; underlying operating profit climbed 55% to £2.5bn. UBS and others raised price targets after strong results and resumed dividends.
3 October 2025
···
Vietnam’s Crypto Gold Rush: Binance, Bybit & Korean Custodian BDACS Supercharge Da Nang’s Digital Finance Hub

Bitcoin Surges Past $120K in “Uptober” Rally – Is a New ATH Looming?

Bitcoin surged above $120,000 for the first time since August 2025, reaching nearly $121,000 on Oct. 2 before settling near $119,000–$120,000. U.S. spot Bitcoin ETFs saw record inflows, with $676 million on Oct. 1 and $627 million on Oct. 2, pushing total ETF assets over $59 billion. Ethereum rose to $4,467, while MicroStrategy added 196 BTC, raising its holdings to 640,031 BTC.
3 October 2025
·····
Humana (HUM) Stock Skyrockets on Medicare News – What Investors Must Know Today

Humana (HUM) Stock Skyrockets on Medicare News – What Investors Must Know Today

Humana shares jumped over 6% to $272.05 midday Oct 3 after the company reported a sharp rise in Medicare Advantage star ratings for 2026. The stock rebounded from last week’s drop, which followed news of Humana cutting its Medicare Advantage footprint. Wall Street consensus remains neutral, with a $289 average price target. Year-to-date, shares are flat and about 19% below their 52-week high.
3 October 2025
·
Cidara Therapeutics (CDTX) Surges on Accelerated Flu Drug Trial – Key Updates for Investors

Cidara Therapeutics (CDTX) Stock Soars After $339M BARDA Flu-Drug Deal – Is CD388 the Next Big Flu-Fighter?

Cidara shares jumped 5.7% to $104.13 Friday morning, nearing a 52-week high after winning a BARDA award worth up to $339 million for its flu drug CD388. The stock is up over 200% year-to-date, with analysts raising price targets as high as $173. Cidara reported $516.9 million in cash and a Q2 net loss of $25.7 million. Short interest stands at 11.3% of float.
3 October 2025
··
🚀 CleanSpark (CLSK) Stock Surges on $120K Bitcoin Rally and $200M Crypto Credit Boost

🚀 CleanSpark (CLSK) Stock Surges on $120K Bitcoin Rally and $200M Crypto Credit Boost

CleanSpark shares rose 6.3% to $16.10 midday Oct. 3, with volume spiking to 13.7 million, far above the three-month average. The company announced two new $100 million bitcoin-backed credit lines this week, bringing total crypto-backed lending to $400 million. CleanSpark holds about 13,011 BTC and operates a 50 EH/s mining fleet. Analyst consensus rates the stock a moderate buy, with an average 12-month target of $20.36.
3 October 2025
···
Coal Comeback Sends Peabody Energy (BTU) Stock Soaring – Real-Time Update & Analyst Insights

Coal Comeback Sends Peabody Energy (BTU) Stock Soaring – Real-Time Update & Analyst Insights

Peabody Energy shares rose about 5.9% to $31 Friday morning, with heavy trading volume. The company faces arbitration from Anglo American after walking away from a $3.78 billion coal asset deal. Peabody reported a Q2 net loss of $27.6 million but holds net cash of $192 million. Analysts remain mixed, with a consensus “Moderate Buy” and average 12-month target of $22–24.
3 October 2025
·
Eos Energy (EOSE) Stock Skyrockets on Big Moves – What’s Fueling the Surge?

Eos Energy (EOSE) Stock Skyrockets on Big Moves – What’s Fueling the Surge?

Eos Energy (NASDAQ: EOSE) surged 22% this week, hitting multi-year highs near $12 as trading volumes spiked. Q2 revenue reached a record $15.2 million, with shipments up 122% quarter-over-quarter. Insiders, including the CEO and CFO, sold shares in Q3, and the company filed to issue 7.33 million new shares on Oct 2. Wall Street remains mixed, with most analysts rating the stock “Hold.”
3 October 2025
··
Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health shares traded near $19.81 midday Oct. 3, up about 2.8%, with a market cap around $4.9 billion. The company reported Q2 revenue of $2.86 billion and a $228 million net loss, serving about 2 million members, mostly in ACA exchanges. On Sep. 11, Oscar announced a $350 million convertible note offering to fund growth and retire its credit line. Analyst ratings remain cautious, with recent downgrades citing ACA risk.
3 October 2025
·
Bitcoin Miner to AI Cloud Sensation: Why Iris Energy (IREN) Stock Is Soaring in 2025

Iris Energy Rockets to Record High Amid AI Mining Frenzy – Is the Rally Sustainable?

Iris Energy (IREN) traded near $49.00 on Oct. 3, up 4.2% intraday and near a record high after surging nearly 500% in a year. The company doubled its AI cloud GPU fleet to 23,000 and posted FY2025 revenue of $501 million, up 168% year-over-year. Analysts raised price targets to as high as $82, though JPMorgan cited valuation risks. IREN now outpaces peers Marathon and Riot in both market cap and stock gains.
3 October 2025
···
White Mountains Stock Skyrockets on $1.75B Bamboo Deal and Major CEO Shake-Up

White Mountains Stock Skyrockets on $1.75B Bamboo Deal and Major CEO Shake-Up

White Mountains shares surged about 9.3% to $1,820 midday Oct. 3 after announcing a $1.75 billion sale of its Bamboo insurance platform to CVC Capital. The deal brings in roughly $840 million in cash and adds about $310 to book value per share. Year-to-date, WTM stock remains down 5.7%. CEO Manning Rountree will retire at year-end, with President/CFO Liam Caffrey set to succeed him.
3 October 2025
··
Sandisk (SNDK) Stock Report – October 3, 2025

Sandisk (SNDK) Stock Report – October 3, 2025

SanDisk’s flash-memory division spun off from Western Digital and relisted as NASDAQ:SNDK on Feb. 24, 2025. Shares surged over 215% year-to-date, closing at $124 on Oct. 3 with a $19.7 billion market cap. The company opened a new 218-layer flash fab in Japan and increased data-center sales to 12% of revenue. Analysts rate the stock a strong buy, but warn of high valuation and industry cyclicality.
3 October 2025
··
Biotech Breakthrough: GRAIL (GRAL) Stock Surges on New Cancer-Detection Data

Biotech Breakthrough: GRAIL (GRAL) Stock Surges on New Cancer-Detection Data

GRAL shares surged to $69.14 intraday on Oct 3, up nearly 6.8% and about 248% year-to-date. Market cap reached $2.3–2.5 billion, a 472% jump since mid-2024, despite ongoing losses and negative EPS. Wall Street consensus remains “Hold” with a $31.50 average price target, far below current levels. Investors await new PATHFINDER 2 trial data at ESMO Congress later this month.
3 October 2025
···
Opendoor Stock Surges on Shopify COO Move – Will AI Magic Keep It Rising?

Opendoor Stock Surges on Shopify COO Move – Will AI Magic Keep It Rising?

Opendoor shares surged 6.8% to $8.56 mid-morning Oct. 3, up about 401% year-to-date after appointing Kaz Nejatian as CEO and announcing AI-driven plans. Q2 revenue reached up to $1.6 billion with a $23 million adjusted EBITDA profit, but weak Q3 guidance sent the stock down 11% in August. Wall Street remains skeptical, with an average 12-month price target of $1.26.
3 October 2025
····
Lithium Americas (LAC) Soars as US Govt Takes 5% Stake – Analysts Weigh In on EV Lithium Boom

Lithium Americas (LAC) Soars as US Govt Takes 5% Stake – Analysts Weigh In on EV Lithium Boom

Lithium Americas shares jumped 28% to C$12.23 on the TSX by midday Friday, hitting a 52-week high after the U.S. Department of Energy took a 5% equity stake and restructured a $2.26 billion loan for the Thacker Pass project. Trading volume topped 2.47 million shares. LAC agreed to draw an initial $435 million tranche of the loan. Analysts remain cautious, noting the company is still pre-revenue.
3 October 2025
··
Quantum Computing Inc (QUBT) Stock Skyrockets on $500M Fundraising and New Tech Debut – Can the Rally Last?

Quantum Computing Inc (QUBT) Stock Skyrockets on $500M Fundraising and New Tech Debut – Can the Rally Last?

Quantum Computing Inc. (QUBT) shares traded near $19.98 on Oct. 3, up about 5% after rebounding from an 11.4% drop the previous day. The stock has swung between $0.65 and $27.15 over the past year, with trading volume surging to 45 million shares on Oct. 2. QUBT completed a $500 million private placement in late September and debuted a new product at the ECOC conference. CEO Bill McGann retired in May; Dr. Yuping Huang is interim CEO.
3 October 2025
··
Palantir’s Shocking Reinvention: From Secretive Spy Tech to $400B Cult Lifestyle Brand

Palantir Stock Skyrockets on Boeing AI Partnership – Analysts Weigh In

Palantir shares traded near $184.50 at 9:48 a.m. ET on Oct. 3, down 1.4% but still close to record highs after a Boeing Defense partnership announcement last week. The stock has more than doubled year-to-date, boosted by record Q2 revenue and raised full-year guidance. Analyst targets range from $45 to $215, with consensus around $125–$140. Trading volume remains elevated amid heavy investor interest.
3 October 2025
···
Mesoblast Stock Jumps on Ryoncil Milestone – Analysts See 40% Upside

Mesoblast Stock Jumps on Ryoncil Milestone – Analysts See 40% Upside

Mesoblast shares closed at $17.02 on Oct. 2, up 4.6% after the FDA-approved Ryoncil won permanent CMS reimbursement via a new J-code. The company confirmed its cell therapies are made from U.S. donors and not subject to tariffs. Wall Street consensus is “Buy” with a $24 average price target. Hedge funds have increased stakes, but overall institutional ownership remains low.
3 October 2025
··
USA Rare Earth (USAR) Stock Skyrockets on Major UK Acquisition and White House Talks

USA Rare Earth (USAR) Stock Explodes on Trump Admin Talks, $100M UK Acquisition & Rare Earth Rally

USA Rare Earth (NASDAQ: USAR) closed at $22.71 on Oct 2, up 23% with record volume, and traded near $25–26 pre-market Oct 3 after hitting a 52-week high. The surge followed news of CEO Barbara Humpton’s appointment, White House talks, and a $100 million UK acquisition. Shares have gained 98% year-to-date, with a market cap of $2.6 billion. Analyst targets lag current prices, signaling possible volatility.
3 October 2025
··
1 … 259 260 261 262 263 … 358
Go toTop